BioCorRx (BICX) Non-Current Deffered Revenue (2013 - 2024)
BioCorRx's (BICX) quarterly Non-Current Deffered Revenue came in at $4045.0 in Q1 2024, little changed year-on-year from $4045.0 in Q2 2023, and little changed quarter-over-quarter from $4045.0 in Q4 2023.
BioCorRx (BICX) Non-Current Deffered Revenue (2013 - 2024) Analysis & Trends
BioCorRx has disclosed Non-Current Deffered Revenue across 12 years of filings, most recently posting $4045.0 for Q1 2024.
- Non-Current Deffered Revenue for Q1 2024 came in at $4045.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2024 was $4045.0 (changed 0.0% YoY), and the FY2023 annual result was $4045.0, changed 0.0% from the prior year.
- Non-Current Deffered Revenue came in at $4045.0 for Q1 2024 at BioCorRx, roughly flat from $4045.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $1.2 million in Q2 2020 to a low of $4045.0 in Q4 2022.
- The 5-year median for Non-Current Deffered Revenue is $19954.0 (2022), against an average of $105104.3.
- Across the five-year window, Non-Current Deffered Revenue jumped 584.03% in 2020 and slumped 89.16% in 2022, its largest moves.
- BioCorRx's Non-Current Deffered Revenue stood at $65560.0 in 2020, then slumped by 43.1% to $37301.0 in 2021, then plunged by 89.16% to $4045.0 in 2022, then changed by 0.0% to $4045.0 in 2023, then changed by 0.0% to $4045.0 in 2024.
- The last three Non-Current Deffered Revenue figures came in at $4045.0 (Q1 2024), $4045.0 (Q4 2023), and $4045.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | - |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | - |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | - |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | - |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 86.28 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | - |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | - |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 142.66 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | - |
| 10 | BioCorRx | - | - | 189,355.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 4,045.00 |
| Dec 31, 2023 | 4,045.00 |
| Sep 30, 2023 | 4,045.00 |
| Jun 30, 2023 | 4,045.00 |
| Mar 31, 2023 | 4,045.00 |
| Dec 31, 2022 | 4,045.00 |
| Sep 30, 2022 | 11,137.00 |
| Jun 30, 2022 | 19,954.00 |
| Mar 31, 2022 | 28,675.00 |
| Dec 31, 2021 | 37,301.00 |
| Mar 31, 2021 | 63,656.00 |
| Dec 31, 2020 | 65,560.00 |
| Sep 30, 2020 | 78,402.00 |
| Jun 30, 2020 | 1.15 Mn |
| Mar 31, 2020 | 94,592.00 |
| Sep 30, 2019 | 139,604.00 |
| Jun 30, 2019 | 168,563.00 |
| Mar 31, 2019 | 197,207.00 |
| Dec 31, 2018 | 207,523.00 |
| Sep 30, 2018 | 245,935.00 |